Investor
LSX World Congress
An executive level partnering and investment event for life science and healthtech companies seeking capital and corporate partnerships.
- When
- May, Mid May
- Where
- London, United Kingdom
- Format
- In person
- Organiser
- LSX
- Region
- Europe
- Scale
- About 1,500 attendees
- Founded
- 2014
The briefing
The LSX World Congress is designed for senior executives in biotech, medtech, and digital health. It focuses on corporate strategy, financing, and business development for high growth healthcare companies. The event matches executive leadership with active life science investors and large pharmaceutical commercial partners. It provides a more intimate environment than massive trade shows, allowing for focused strategic discussions and peer to peer networking.
What to expect
- Series A and B investment announcements
- Pharma licensing and acquisition discussions
- Commercialization strategies for clinical software
- Boardroom governance and financing advice
Who is in the room
Life science chief executive officers, venture capital partners, pharma licensing executives, and corporate development directors attend.
Background
LSX was established to create a highly focused meeting space for European life science leaders. It has grown from a local UK gathering into a global platform with sister events in North America and Asia.
Related events
Running this event, or spotted something out of date?